熊绍权教授 中西医结合临床
博士后（中西结合肿瘤），博士（西医肿瘤），硕士（中医肿瘤），军医转业。四川省中医药管理局学术和技术带头人，成都市中医药专家经验师承指导老师，四川省肿瘤康复专委会副主任委员。先后师从必赢唯一官方网站原肿瘤科主任、中医肿瘤资深名医刘碧清教授，师从全国著名肿瘤学专家、华西医院魏于全院士，师从第三届国医大师、全国著名中医肿瘤专家周岱翰教授。先后2次在中山大学肿瘤医院进修深造，参加多项国家抗癌研究，包括863、973项目，以第一负责人主持国家自然基金项目、教育部博士点专项、中国博士后科学基金面上项目和特别资助项目等。熟悉分子病理学、分子细胞生物学等生物医学研究，率先在国内开展针对肺癌不同分子靶点的中西医诊疗，率先开展以纯中药治疗晚期肝细胞癌前瞻性临床研究，率先从临床和基础层面研究中医药防治化疗外周神经损害的疗效机制，首例报道以纯中药治疗脑转移小细胞肺癌、脑转移ALK阳性靶向耐药肺腺癌等。主编参编肿瘤学专著2部、全国性医院专科规培教材1部。
研究领域
肿瘤的中西医结合防治基础和临床研究
出版信息
论文：
(1) XIONG Shao-quan, CHEN Yu , WANG Li-juan, LYU Pan-pan , LIAO Wan , WANG Cui , KE Jian-long , ZHU Xi , WANG Jin-yang , SHEN Xian-ying , LI Guang-ping , and LIN Li- zhu * .Usage of Chinese Herbs in Cancer Patients in Southern China: A Survey. Chinese Journal of Integrative Medicine. Med 2021 Jul;27(7):502-508
(2) Yujia Wang, Guoyu Wu, Ru Li , Yingzhe Luo , Xingmei Huang , Lifang He , Huihui Zhong and Shaoquan Xiong*. Chinese Medicine Combined With EGFR-TKIs Prolongs Progression- Free Survival and Overall Survival of Non-small Cell Lung Cancer (NSCLC) Patients Harboring EGFR Mutations, Compared With the Use of TKIs Alone. Frontiers in Public Health. 2021 Jun 18;9:677862.
(3) Lijuan Wang, Jianlong Ke, , Cui Wang , Yaling Li, Guoyu Wu, Qian Ding, Qiuyue Luo, , Rui Ca, Panpan Lv, Tingting Song, and Shaoquan Xiong *.. Efficacy and Safety of Banxia XieXin Decoction, a Blended Traditional Chinese Medicine, as Monotherapy for Patients With Advanced Hepatocellular Carcinoma.Integr Cancer Ther. Jan-Dec 2020;19:1534735420942587.
(4) Panpan Lv , Xi Zhu, Jingyang Wang, Guangping Li, Xian Ying Shen, Jianlong Ke, Cui Wang, and Shaoquan Xiong * .Experimental Study of Shenfu Injection on the Prevention and Treatment of Paclitaxel Chemotherapy DRG Neuron Injury.Evid Based Complement Alternat Med. 2020 Feb 17;2020:8239650.
(5) Guoyu Wu, Jianlong Ke, Jinyang Wang, Xi Zhu, Shaoquan Xiong* .LncRNA CCAT2 promotes the proliferation and invasion of renal cell cancer by sponging miR-320a. Edizioni Minerva Medica. Med. 2020 Jan 20.